Please select the option that best describes you:
Topics:
Hematologic Malignancies • Medical Oncology • Lymphoma • NCI-CCC Tumor Board Question • Internal Medicine • Hematology • UC Irvine • NCI-CCC Lymphoma Tumor Board Question
How would you approach therapy for a patient with newly diagnosed non-GC DLBCL with previous anthracycline exposure?
240-300 mg/m2 prior exposure. How would your management change in young fit/older individuals with comorbidities? Would you obtain interval TTE during treatment?
Answer from: Medical Oncologist at Academic Institution
For fit patients with prior anthracycline exposure for non-lymphoma healthcare who are fit for chemotherapy and with preserved LV function, I would recommend considering daR-EPOCH. The history of the regimen was its original development as treatment of relapsed lymphoma after 1L bolus doxorubicin, a...
Sign in or Register to read more
Answer from: Medical Oncologist at Community Practice
In a young individual, I would be very reluctant to give an anthracycline, given previous exposure. It is preferred to use a chemotherapy combination that the patient has not been treated with previously, which may be associated with higher response rates. If transplant-eligible, a salvage regimen s...